217 related articles for article (PubMed ID: 15570431)
1. MAGE-A3 is a frequent tumor antigen of metastasized melanoma.
Roeder C; Schuler-Thurner B; Berchtold S; Vieth G; Driesch Pv; Schuler G; Lüftl M
Arch Dermatol Res; 2005 Jan; 296(7):314-9. PubMed ID: 15570431
[TBL] [Abstract][Full Text] [Related]
2. Detection of MAGE-A3 in breast cancer patients' sentinel lymph nodes.
Wascher RA; Bostick PJ; Huynh KT; Turner R; Qi K; Giuliano AE; Hoon DS
Br J Cancer; 2001 Nov; 85(9):1340-6. PubMed ID: 11720472
[TBL] [Abstract][Full Text] [Related]
3. Melanoma-associated antigens in esophageal adenocarcinoma: identification of novel MAGE-A10 splice variants.
Lin J; Lin L; Thomas DG; Greenson JK; Giordano TJ; Robinson GS; Barve RA; Weishaar FA; Taylor JM; Orringer MB; Beer DG
Clin Cancer Res; 2004 Sep; 10(17):5708-16. PubMed ID: 15355897
[TBL] [Abstract][Full Text] [Related]
4. The melanoma antigen gene as a surveillance marker for the detection of circulating tumor cells in patients with breast carcinoma.
Kwon S; Kang SH; Ro J; Jeon CH; Park JW; Lee ES
Cancer; 2005 Jul; 104(2):251-6. PubMed ID: 15937912
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneous expression of MAGE-A genes in occult disseminated tumor cells: a novel multimarker reverse transcription-polymerase chain reaction for diagnosis of micrometastatic disease.
Kufer P; Zippelius A; Lutterbüse R; Mecklenburg I; Enzmann T; Montag A; Weckermann D; Passlick B; Prang N; Reichardt P; Dugas M; Köllermann MW; Pantel K; Riethmüller G
Cancer Res; 2002 Jan; 62(1):251-61. PubMed ID: 11782385
[TBL] [Abstract][Full Text] [Related]
6. MAGE-12 and MAGE-6 are frequently expressed in malignant melanoma.
Gibbs P; Hutchins AM; Dorian KT; Vaughan HA; Davis ID; Silvapulle M; Cebon JS
Melanoma Res; 2000 Jun; 10(3):259-64. PubMed ID: 10890380
[TBL] [Abstract][Full Text] [Related]
7. Activation of melanoma antigen tumor antigens occurs early in lung carcinogenesis.
Jang SJ; Soria JC; Wang L; Hassan KA; Morice RC; Walsh GL; Hong WK; Mao L
Cancer Res; 2001 Nov; 61(21):7959-63. PubMed ID: 11691819
[TBL] [Abstract][Full Text] [Related]
8. A multimarker real-time RT-PCR for MAGE-A gene expression allows sensitive detection and quantification of the minimal systemic tumor load in patients with localized cancer.
Mecklenburg I; Weckermann D; Zippelius A; Schoberth A; Petersen S; Prang N; Riethmüller G; Kufer P
J Immunol Methods; 2007 Jun; 323(2):180-93. PubMed ID: 17540401
[TBL] [Abstract][Full Text] [Related]
9. Melanoma antigen-1 mRNA combined with alpha-fetoprotein mRNA levels in peripheral blood of patients with hepatocellular carcinoma: a predictor of postoperative recurrence or metastasis?
Zhang Y; Song T; Meng L; Wu X; Ba Y; Li Q
ANZ J Surg; 2009; 79(1-2):62-9. PubMed ID: 19183381
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast growth factor 2 and estrogen control the balance of histone 3 modifications targeting MAGE-A3 in pituitary neoplasia.
Zhu X; Asa SL; Ezzat S
Clin Cancer Res; 2008 Apr; 14(7):1984-96. PubMed ID: 18381936
[TBL] [Abstract][Full Text] [Related]
11. [Melanoma antigen-3 expression in human hepatocellular carcinoma].
Cai S; Zhao H; Leng X; Cheng J; Gong S; Peng J; Cong X; Wang Y; Rui J; Hui Y; Du R; Chen W
Zhonghua Wai Ke Za Zhi; 2000 Sep; 38(9):693-6. PubMed ID: 11832142
[TBL] [Abstract][Full Text] [Related]
12. [Expression of melanoma antigen gene in urinary transitional cell carcinomas].
Geng L; Yu LZ; Du P; Ma M; Na YQ
Zhonghua Wai Ke Za Zhi; 2005 May; 43(10):667-71. PubMed ID: 16008943
[TBL] [Abstract][Full Text] [Related]
13. [Detection of alpha-fetoproteins mRNA and melanoma antigen-1 mRNA in peripheral blood of patients with hepatocellular carcinoma and its clinical significance].
Yang SZ; Dong JH; Zhu J; Li K; Zhang Y
Zhonghua Wai Ke Za Zhi; 2004 Sep; 42(17):1060-3. PubMed ID: 15498320
[TBL] [Abstract][Full Text] [Related]
14. Detection of circulating lymphoma cells in patients with non-Hodgkin lymphoma using MAGE-A3 gene expression in peripheral blood.
Han MH; Eom HS; Park WS; Yun T; Park S; Kim HJ; Jeon CH; Kong SY
Leuk Res; 2010 Sep; 34(9):1127-31. PubMed ID: 20036422
[TBL] [Abstract][Full Text] [Related]
15. Molecular and biochemical testing in stage III melanoma: multimarker reverse transcriptase-polymerase chain reaction assay of lymph fluid after lymph node dissection and preoperative serum lactate dehydrogenase level.
Nowecki ZI; Rutkowski P; Kulik J; Siedlecki JA; Ruka W
Br J Dermatol; 2008 Sep; 159(3):597-605. PubMed ID: 18616789
[TBL] [Abstract][Full Text] [Related]
16. Tumor antigen expression in melanoma varies according to antigen and stage.
Barrow C; Browning J; MacGregor D; Davis ID; Sturrock S; Jungbluth AA; Cebon J
Clin Cancer Res; 2006 Feb; 12(3 Pt 1):764-71. PubMed ID: 16467087
[TBL] [Abstract][Full Text] [Related]
17. mRNA expression of MAGE-A3 gene in leukemia cells.
Martínez A; Olarte I; Mergold MA; Gutiérrez M; Rozen E; Collazo J; Amancio-Chassin O; Ordóñez RM; Montesinos JJ; Mayani H; McCurdy DK; Ostrosky-Wegman P; Garrido-Guerrero E; Miranda EI
Leuk Res; 2007 Jan; 31(1):33-7. PubMed ID: 16806467
[TBL] [Abstract][Full Text] [Related]
18. NY-ESO-1 and CTp11 expression may correlate with stage of progression in melanoma.
Goydos JS; Patel M; Shih W
J Surg Res; 2001 Jun; 98(2):76-80. PubMed ID: 11397121
[TBL] [Abstract][Full Text] [Related]
19. MAGE-3 immunoreactivity in formalin-fixed, paraffin-embedded primary and metastatic melanoma: frequency and distribution.
Hofbauer GF; Schaefer C; Noppen C; Böni R; Kamarashev J; Nestle FO; Spagnoli GC; Dummer R
Am J Pathol; 1997 Dec; 151(6):1549-53. PubMed ID: 9403705
[TBL] [Abstract][Full Text] [Related]
20. Immunoreactivity with the anti-MAGE antibody 57B in malignant melanoma: frequency of expression and correlation with prognostic parameters.
Busam KJ; Iversen K; Berwick M; Spagnoli GC; Old LJ; Jungbluth AA
Mod Pathol; 2000 Apr; 13(4):459-65. PubMed ID: 10786815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
